Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment

Aplastic anemia (AA) is characterized by bone marrow (BM) hypocellularity, resulting in peripheral cytopenias. An antigen-driven and likely auto-immune dysregulated T-cell homeostasis results in hematopoietic stem cell injury, which ultimately leads to the pathogenesis of the acquired form of this d...

Full description

Bibliographic Details
Main Authors: Michael Medinger, Beatrice Drexler, Claudia Lengerke, Jakob Passweg
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2018.00587/full
_version_ 1818689098238394368
author Michael Medinger
Michael Medinger
Beatrice Drexler
Claudia Lengerke
Jakob Passweg
author_facet Michael Medinger
Michael Medinger
Beatrice Drexler
Claudia Lengerke
Jakob Passweg
author_sort Michael Medinger
collection DOAJ
description Aplastic anemia (AA) is characterized by bone marrow (BM) hypocellularity, resulting in peripheral cytopenias. An antigen-driven and likely auto-immune dysregulated T-cell homeostasis results in hematopoietic stem cell injury, which ultimately leads to the pathogenesis of the acquired form of this disease. Auto-immune and inflammatory processes further influence the disease course as well as response rate to therapy, mainly consisting of intensive immunosuppressive therapy and allogeneic hematopoietic cell transplantation. Bone marrow hematopoietic stem and progenitor cells are strongly regulated by the crosstalk with the surrounding microenvironment and its components like mesenchymal stromal cells, also consistently altered in AA. Whether latter is a contributing cause or rather consequence of the disease remains an open question. Overall, niche disruption may contribute to disease progression, sustain pancytopenia and promote clonal evolution. Here we review the existing knowledge on BM microenvironmental changes in acquired AA and discuss their relevance for the pathogenesis and therapy.
first_indexed 2024-12-17T12:04:42Z
format Article
id doaj.art-1c0c80331c4546aaad66d932892e8e9b
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-17T12:04:42Z
publishDate 2018-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-1c0c80331c4546aaad66d932892e8e9b2022-12-21T21:49:41ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2018-12-01810.3389/fonc.2018.00587414997Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow MicroenvironmentMichael Medinger0Michael Medinger1Beatrice Drexler2Claudia Lengerke3Jakob Passweg4Division of Internal Medicine, Department of Medicine, University Hospital Basel, Basel, SwitzerlandDivision of Hematology, Department of Medicine, University Hospital Basel, Basel, SwitzerlandDivision of Hematology, Department of Medicine, University Hospital Basel, Basel, SwitzerlandDivision of Hematology, Department of Medicine, University Hospital Basel, Basel, SwitzerlandDivision of Hematology, Department of Medicine, University Hospital Basel, Basel, SwitzerlandAplastic anemia (AA) is characterized by bone marrow (BM) hypocellularity, resulting in peripheral cytopenias. An antigen-driven and likely auto-immune dysregulated T-cell homeostasis results in hematopoietic stem cell injury, which ultimately leads to the pathogenesis of the acquired form of this disease. Auto-immune and inflammatory processes further influence the disease course as well as response rate to therapy, mainly consisting of intensive immunosuppressive therapy and allogeneic hematopoietic cell transplantation. Bone marrow hematopoietic stem and progenitor cells are strongly regulated by the crosstalk with the surrounding microenvironment and its components like mesenchymal stromal cells, also consistently altered in AA. Whether latter is a contributing cause or rather consequence of the disease remains an open question. Overall, niche disruption may contribute to disease progression, sustain pancytopenia and promote clonal evolution. Here we review the existing knowledge on BM microenvironmental changes in acquired AA and discuss their relevance for the pathogenesis and therapy.https://www.frontiersin.org/article/10.3389/fonc.2018.00587/fullaplastic anemiamicroenvironmentmicrovessel densitymesenchymal stem cellsstem cell niche
spellingShingle Michael Medinger
Michael Medinger
Beatrice Drexler
Claudia Lengerke
Jakob Passweg
Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
Frontiers in Oncology
aplastic anemia
microenvironment
microvessel density
mesenchymal stem cells
stem cell niche
title Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
title_full Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
title_fullStr Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
title_full_unstemmed Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
title_short Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
title_sort pathogenesis of acquired aplastic anemia and the role of the bone marrow microenvironment
topic aplastic anemia
microenvironment
microvessel density
mesenchymal stem cells
stem cell niche
url https://www.frontiersin.org/article/10.3389/fonc.2018.00587/full
work_keys_str_mv AT michaelmedinger pathogenesisofacquiredaplasticanemiaandtheroleofthebonemarrowmicroenvironment
AT michaelmedinger pathogenesisofacquiredaplasticanemiaandtheroleofthebonemarrowmicroenvironment
AT beatricedrexler pathogenesisofacquiredaplasticanemiaandtheroleofthebonemarrowmicroenvironment
AT claudialengerke pathogenesisofacquiredaplasticanemiaandtheroleofthebonemarrowmicroenvironment
AT jakobpassweg pathogenesisofacquiredaplasticanemiaandtheroleofthebonemarrowmicroenvironment